Research Wiki https://research-2ry.pages.dev 最新の10件 on Research Wiki Quartz -- quartz.jzhao.xyz Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy. https://research-2ry.pages.dev/Summary/Clinical-irAE/JImmunotherCancer-2021-Halle-Immune-checkpoint-inhibitors-in-patients-with-pre-existing-psoriasis-Safety-and-efficacy https://research-2ry.pages.dev/Summary/Clinical-irAE/JImmunotherCancer-2021-Halle-Immune-checkpoint-inhibitors-in-patients-with-pre-existing-psoriasis-Safety-and-efficacy Thu, 02 Jul 2026 09:20:56 GMT Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies https://research-2ry.pages.dev/Summary/Clinical-Thymic/TrendsCancer-2023-Caruso-Thymic-expression-of-immune-checkpoint-molecules-and-their-implication-for-response-to-immunotherapies https://research-2ry.pages.dev/Summary/Clinical-Thymic/TrendsCancer-2023-Caruso-Thymic-expression-of-immune-checkpoint-molecules-and-their-implication-for-response-to-immunotherapies Thu, 02 Jul 2026 09:20:56 GMT Staging system of thymoma https://research-2ry.pages.dev/Summary/Clinical-Thymic/JThoracOncol-2010-Masaoka-Staging-system-of-thymoma https://research-2ry.pages.dev/Summary/Clinical-Thymic/JThoracOncol-2010-Masaoka-Staging-system-of-thymoma Thu, 02 Jul 2026 09:20:55 GMT Thymus organogenesis https://research-2ry.pages.dev/Summary/Clinical-Thymic/AnnuRevImmunol-2008-Rodewald-Thymus-organogenesis https://research-2ry.pages.dev/Summary/Clinical-Thymic/AnnuRevImmunol-2008-Rodewald-Thymus-organogenesis Thu, 02 Jul 2026 09:20:55 GMT Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial https://research-2ry.pages.dev/Summary/Clinical-SCLC/Lancet-2019-Paz-Ares-Durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line-treatment-of-extensive-stage-small-cell-lung https://research-2ry.pages.dev/Summary/Clinical-SCLC/Lancet-2019-Paz-Ares-Durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line-treatment-of-extensive-stage-small-cell-lung Thu, 02 Jul 2026 09:20:55 GMT The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study https://research-2ry.pages.dev/Summary/Clinical-SCLC/CancerResTreat-2024-Choi-The-real-world-outcome-of-first-line-atezolizumab-in-extensive-stage-small-cell-lung-cancer-A-multicenter-prospective https://research-2ry.pages.dev/Summary/Clinical-SCLC/CancerResTreat-2024-Choi-The-real-world-outcome-of-first-line-atezolizumab-in-extensive-stage-small-cell-lung-cancer-A-multicenter-prospective Thu, 02 Jul 2026 09:20:55 GMT Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non–Small Cell Lung Cancer https://research-2ry.pages.dev/Summary/Clinical-Others/JCOPrecisOncol-2026-Lovly-Real-world-patient-characteristics,-mutational-landscape,-and-outcomes-in-AdvancedMetastatic https://research-2ry.pages.dev/Summary/Clinical-Others/JCOPrecisOncol-2026-Lovly-Real-world-patient-characteristics,-mutational-landscape,-and-outcomes-in-AdvancedMetastatic Thu, 02 Jul 2026 09:20:55 GMT Recent advances and discoveries in the mechanisms and functions of CAR T cells https://research-2ry.pages.dev/Summary/Clinical-Novel-modalities/NatRevCancer-2021-Larson-Recent-advances-and-discoveries-in-the-mechanisms-and-functions-of-CAR-T-cells https://research-2ry.pages.dev/Summary/Clinical-Novel-modalities/NatRevCancer-2021-Larson-Recent-advances-and-discoveries-in-the-mechanisms-and-functions-of-CAR-T-cells Thu, 02 Jul 2026 09:20:55 GMT Adoptive cell transfer: a clinical path to effective cancer immunotherapy https://research-2ry.pages.dev/Summary/Clinical-Novel-modalities/NatRevCancer-2008-Rosenberg-Adoptive-cell-transfer-a-clinical-path-to-effective-cancer-immunotherapy https://research-2ry.pages.dev/Summary/Clinical-Novel-modalities/NatRevCancer-2008-Rosenberg-Adoptive-cell-transfer-a-clinical-path-to-effective-cancer-immunotherapy Thu, 02 Jul 2026 09:20:55 GMT Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery https://research-2ry.pages.dev/Summary/Clinical-Novel-modalities/NatBiotechnol-2018-Tang-Enhancing-T-cell-therapy-through-TCR-signaling-responsive-nanoparticle-drug-delivery https://research-2ry.pages.dev/Summary/Clinical-Novel-modalities/NatBiotechnol-2018-Tang-Enhancing-T-cell-therapy-through-TCR-signaling-responsive-nanoparticle-drug-delivery Thu, 02 Jul 2026 09:20:55 GMT